Hutch News

For the best stem cells, mimic their native niche

For the best stem cells, mimic their native niche

By the Delaney lab, Clinical Research Division
Science SpotlightNovember 18, 2019
'Something everyone can get': New spinoff to commercialize cord blood stem cell therapies

'Something everyone can get': New spinoff to commercialize cord blood stem cell therapies

New Fred Hutch spinoff to commercialize cord blood stem cell therapies based on work by Drs. Colleen Delaney, Irwin Bernstein
Hutch NewsDecember 03, 2015